首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Mouse CD226 Protein, His Tag

Mouse CD226 Protein, His Tag

产品编号

KMP2322

别名

白细胞分化抗原, CD226 antigen, CD226

规格
  • 50ug
  • 100ug
  • 200ug
产品介绍
Catalog NumberKMP2322
Alias白细胞分化抗原, CD226 antigen, CD226
Size50ug, 100ug, 200ug
Product DescriptionThe Mouse CD226 Protein(KMP2322) is produced in HEK293 Cells and the target gene encoding Glu19-Pro254 is expressed with a 6His tag at the C-terminus.
Molecular NameCD226
Product IntroductionCD226(DNAM-1):免疫球蛋白超家族(IgSF)成员,通过跨膜形式促进免疫细胞对靶细胞的识别。
Molecular Weight27.61 kDa
Expression SystemHEK293 Cells
SpeciesMouse
Purity>95%
SDS-PAGE
PurificationAffinity Purification
Uniprot IDQ8K4F0
Storage ConditionAliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.4
Shipping ConditionIn general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form.
BackgroundMouse DNAX accessory molecule-1(DNAM-1) is a type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily. As an activating receptor, it interacts with the ligands CD155 and CD112, and activates natural killer(NK) cells via its immu-noreceptor tyrosine-based activatory motif(ITAM). Mature mouse DNAM-1 has extracellular domain(ECD) that contains two Ig-like C2-set domains, and possesses a cytoplasmic region that contains motifs for binding PDZ domains. DNAM-1 is expressed on several lymphoid and myeloid cell types and interacts with CD155/PVR and Nectin-2/CD112. Ligation of DNAM-1 promotes the activation of NK cells, CD8+ T cells, and mast cells, induces dendritic cell maturation, initiates megakaryocyte and activated platelet adhesion to vascular endothelial cells, and stimulates monocyte extravasation- Conversely, it inhibits the formation of osteoclasts. Platelet-endothelium interactions that are mediated by DNAM-1 enable the metastasis of tumor cells to the lung.
Endotoxin<1.0 EU/ug determined by the LAL method
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
FAQ
  • 蛋白溶解后浓度偏低,如何调整?

    低速离心:12,000 rpm, 5分钟,去除不溶物。缓冲液置换:使用超滤离心管(如10 kDa截留分子量)浓缩。

  • 如何提高重组蛋白的可溶性表达?

    可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价